@Rae86498311 @unhealthytruth For over six decades reductionist approaches to cancer chemotherapies including recent immunotherapy for solid tumors produced outcome failure-rates of 90% according to governmental agencies and industry. https://t.co/G4U74xbP
@ClowningMad @tommyjoad1 @1roastedchicken @Annatlast @josephedmonds @IanCopeland5 @stkirsch https://t.co/BHFsjcebps Like I said. Just bc they do something for a long time doesn't mean it works. https://t.co/lVTeQEiAsA
@doctorfavorito @bitacorabeagle Lástima su insulto y su mala educación. Y lástima también su falta de conocimiento. Ambas cosas van de la mano, la gente ignorante siempre insulta, es el único recurso que tienen a mano. Le dejo un estudio de revisión de lo
@Burki677 @MissytheMuse @sense_strand @Virus_FOI_Lady @CarlSmytheCells @AndyAve_ @BohemianAtmosp1 you could have cited sources that show the efficacy or effectiveness of chemotherapy and radiation for cancer patients as the counter to GNM. like this one fo
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic ... https://t.co/3yK4d1T9rb Something to think about
@DennisRadTech @cavepaleo @holisticgrenade there is nothing therapeutic about ‘chemotherapy’. chemotoxicity is a more appropriate term because its just a barbaric onslaught of chemical poison that indiscriminately damages all cellular tissue which severely
@AriObanMD @JamesLynchGTC https://t.co/QUw75iziEU Fuck all improvement with trillions spent. Many stories of people being told to go home and die- they used alternative treatments and beat the docs death sentence. Suppressed cures for £££
RT @MD_PhD_ivermect: https://t.co/vyJj0rtBLg 薬剤によって患者の免疫抑制が亢進すると、がん細胞が免疫系からさらに逃れやすくなり、その結果、増殖促進が促進され、がんの再発と転移が起こりやすくなる。
https://t.co/vyJj0rtBLg 薬剤によって患者の免疫抑制が亢進すると、がん細胞が免疫系からさらに逃れやすくなり、その結果、増殖促進が促進され、がんの再発と転移が起こりやすくなる。
@holisticgrenade ... outcome failure-rates of 90% (±5) ... https://t.co/SPlygTTSM2
@_APWK_ 90% failure rate...sounds familiar. "We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors" Quacks. https://t.co/sm2CUdkvkK.
@_kelly_neill_ @EthicalSkeptic And also this one, more recent. https://t.co/B9FDzdnGSc
This.
RT @ja91404569: Here is the article mentioned https://t.co/N85FzPzVyG
Here is the article mentioned https://t.co/N85FzPzVyG
@sanityends @elonmusk @TheBabylonBee Looks like someone doesn't know that the NIH website links to other websites. (It's NOT by the NIH.) https://t.co/1dlq31rAsj
@im_kaz3 @Rainmaker1973 @CommunityNotes Are you trying to denounce facts? When all of the evidence is right in front of you? https://t.co/1dlq31s8hR
Detransition (which does not always mean "failure of transition/gender affirmation," since people often detrans for logistical reasons and retransition once they're able to) has a rate of about 5%. For context, here's the failure rate of chemo. https://t.
Clinical and Translational Medicine- Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. https://t.co/UDsG1uRZh6
RT @Gwg1955: @1tweet4mamkind @awarrior828 Only 10% don't die. "For over six decades reductionist approaches to cancer chemotherapies inclu…
@1tweet4mamkind @awarrior828 Only 10% don't die. "For over six decades reductionist approaches to cancer chemotherapies including recent immunotherapy for solid tumors produced outcome failure-rates of 90%" https://t.co/OADCJwOHqd
@IvanValente Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@nadanovonofront @JornalismoWando Ineficacia nunca foi problema para os medicos. https://t.co/PZXA3kQJCa We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@brasil247 Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@samiabomfim @WesleyZardo Os médicos? Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@CNNBrasil Ele não tem culpa, não é médico, e se fosse, Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approache
@do_genocida @fiocruz Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@jgprates @nadiabambirra @ottoalencar @EduGiraoOficial e tem Médico charlatao. Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on curren
@eubrunabarboza @WesleyZardo Capitao cloroquina e oncologia é a mesma coisa . Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current
@pmartinezsilva @JTrianaGz Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@PCdoB_Oficial Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@g1 Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@folha Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@CNNBrasil Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@luizmuller @CCambara2 Ineficacia nunca foi problema para os medicos. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@folha Como cap. Cloroquina e seus medicos incompetentes, Ineficacia nunca foi problema para eles. https://t.co/eKb8rm6e8U We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches fo
@RafaelBarifouse Ineficacia nunca foi problema para os medicos. https://t.co/PZXA3kQJCa We presented scientific analyses of the disturbing data on the outcome failure rates of 90% (±5) on current therapeutic approaches for solid tumors
@brunocovas Eles são uma fraude. https://t.co/zlePoFNjMy
@CNNBrasil Ele sabem q os métodos são uma fraude? https://t.co/zlePoFNjMy
This should be mandatory reading for all peer reviewers as @theNCI continues to mostly fund the same old shit while those of us working on cutting edge technologies can’t access adequate funding. I’m pissed, and the patients are super pissed. @NIHDirector
RT @cispt2: Realllllly interesting gripes aired in this review. https://t.co/4dnPWwHORM https://t.co/ql5tXYgorC
Realllllly interesting gripes aired in this review. https://t.co/4dnPWwHORM https://t.co/ql5tXYgorC
RT @bayard_horton: @CancerIntegral Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, lo…
@CancerIntegral Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. https://t.co/Xv1WpIT5e4
RT @SmMolecules: Analyses of repeated failures in cancer therapy for solid tumors: https://t.co/eybPFarrLy https://t.co/4GT86EGPJS
Analyses of repeated failures in cancer therapy for solid tumors: https://t.co/eybPFarrLy https://t.co/4GT86EGPJS
Analyses of repeated failures in cancer therapy for solid tumors: https://t.co/eybPFarrLy https://t.co/i3aDQQkYQ3
RT @simonCAMedit: Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic eff…
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable cost... - PubMed - NCBI https://t.co/t8HOtWtxhh
RT @oncology_bg: My goodness, what did I just read! https://t.co/mrgmPaHobX
Brutal. "Claimed ‘targeted’ therapies [and] tremendously costly projects totally disregard suffering & life-altering experiences of patients & families or caregivers. Torturous period of survival overwhelms the benefit of postponing ‘death-sentenc
I don't mean to endorse this article btw. I found the language overly inflammatory. https://t.co/98UImeBgq4
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs via @oncology_bg https://t.co/fESeHluZso
My goodness, what did I just read! https://t.co/mrgmPaHobX